The Current Ratio as of June 2026 (TTM) for Xenon Pharmaceuticals Inc. (XENE) is 27.79

According to Xenon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 27.79. This represents a change of 61.43% compared to the average of 17.22 of the last 4 quarters.

Xenon Pharmaceuticals Inc. (XENE) Historical Current Ratio (quarterly & annually)

How has XENE Current Ratio performed in the past?

The mean historical Current Ratio of Xenon Pharmaceuticals Inc. over the last ten years is 19.52. The current 27.79 Current Ratio has changed 14.14% with respect to the historical average. Over the past ten years (40 quarters), XENE's Current Ratio was at its highest in in the March 2022 quarter at 68.36. The Current Ratio was at its lowest in in the December 2019 quarter at 3.34.

Xenon Pharmaceuticals Inc. (XENE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Xenon Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xenon Pharmaceuticals Inc. (XENE) Average Current Ratio

How has XENE Current Ratio performed in the past?

The current Current Ratio of Xenon Pharmaceuticals Inc. (XENE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Xenon Pharmaceuticals Inc. (XENE) Current Ratio vs. Peers

How is XENE’s Current Ratio compared to its peers?

Xenon Pharmaceuticals Inc.’s Current Ratio is greater than Centessa Pharmaceuticals plc (9.53), less than Apogee Therapeutics, Inc. (32.59), greater than Ascentage Pharma Group International (1.79), greater than Ultragenyx Pharmaceutical Inc. (2.02), greater than Celcuity Inc. (12.31), greater than Zai Lab Limited (2.40), less than CG Oncology, Inc. Common stock (31.30), greater than Scholar Rock Holding Corporation (8.64), greater than Travere Therapeutics, Inc. (3.13), greater than Legend Biotech Corporation (2.13),

Build a custom stock screener for Xenon Pharmaceuticals Inc. (XENE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xenon Pharmaceuticals Inc. (XENE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xenon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.